It’s time for a change. We are not here to curse the traditional pharmaceutical ways.
We are here to light a candle.
“If we open a quarrel between the future and the past,
we shall be in danger of losing the future.” Winston Churchill
Today, our concern must be the future. Your future.
Our future. For the world is changing and the people with it.
That’s why our mission is to bring the microbiome to the traditional pharma.
Our mission revolves around
Exeliom Biosciences’ approach is rooted in a strong clinical rationale that makes it worth
the journey to explore new microbiome fields and overcome their challenges.
This rationale derives from a thorough and tireless observation of the patients’ conditions.
to cross the next frontier..
While companies developing single bacterial-strain therapies have been focusing on low-hanging fruits until now, Exeliom Biosciences took up the challenge to unlock the therapeutic potential of one of the most fastidious and promising gut bacteria:
Faecalibacterium prausnitzii (F. prau). We have cultured the unculturable and we have made it possible to conceive a well-defined and purified drug exploiting the remarkable properties of this star gut bacterium.
and give you a fair chance to fight
Our thinking is deeply rooted in you, the patients. Our first mission is to overcome the
obstacles associated with highly promising, yet fastidious, bacteria. Then, we will make an
F. prau-based drug for you. This drug is to give you the same resources as healthy
subjects so that your body can fight.
Oops! Something went wrong while submitting the form.